Wednesday, March 13, 2013

Painless Jaundice!



This morning we discussed an interesting case of a patient with painless jaundice after receiving multiple courses of antibiotics, including septra, for a presumed cellulitis.

Here is an approach to painless jaundice (not an exhaustive list):

1) Prehepatic causes:

  • Hemolysis: i.e. AIHA, G6PD with offending drug
  • Impaired hepatic bilirubin conjugation: Gilbert's, Crigler Najjar
2) Intra-hepatic causes:
  • Inflammatory: Primary biliary cirrhosis, primary sclerosing cholangitis
  • Malignant: Cholangiocarcinoma, hepatocellular carcinoma
  • Infectious: Chlonorcus senensis (Chinese liver fluke), Ascaris lumbricoides, Viral: HBV, HCV, EBV, CMV (but usually produces more hepatocellular picture rather than a cholestatic picture), alcoholic hepatitis
  • Drug induced liver injury
  • Other: NASH, liver infiltration (amyloid, sarcoid, lymphoma)
3) Post-hepatic causes:
  • Cholelithiasis: common bile duct obstruction, Mirizzi syndrome where distended gallbladder causes obstruction of extrahepatic bile duct
  • Pancreatic neoplasm
  • Stricture post instrumentation
A little more on Drug Induced Liver Injury (DILI)

1) Types of DILI:
  • Can mimic all patterns observed in primary liver disease
    • Acute hepatocellular injury: increased ALT/ALP ratio
    • Cholestatic injury: Isolated increase in ALP, with decrease in ALT/ALP ratio
    • Granulomatous hepatitis
    • Steatohepatitis
    • Can present as acute or chronic liver injury
  • Acute hepatocellulary injury and fulminant liver failure:
    • Examples of drugs that cause acute fulminant hepatitis include: acetaminophen, isoniazid, sulfonamides, cotrimoxazole, ketoconazole, anticonvulsants
  • Acute Cholestatic injury:
    • Presents clinically with jaundice, pruritis, dark urine and pale stools
    • Liver enzymes reveal elevated ALP, GGT and Bili.
    • Common culprit drugs include: anabolic steroids, oral contraceptives, prochlorperazine, and antibiotics (septra and erythromycin)
  • See the following articles for more information:

No comments :